Otologic Pharmaceutics
PrivateLast Round
Grant
Jul 30, 2020
Total Funding Raised
$11.7M
Company Overview
Otologic Pharmaceutics operates in Healthcare & Life Sciences and is based in Oklahoma City, Oklahoma. Its latest recorded funding round was a Grant round in July 2020.
Otologic Pharmaceutics is a biopharmaceutical company that develops treatments for acute and chronic hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Otologic Pharmaceutics Comparables
Compare Otologic Pharmaceutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gateway Biotechnology, Inc. | 88% | |
| Sound Pharmaceuticals, Inc. | 85% | |
| AudioCure Pharma | 84% |
For institutional investors. Book with your work email.
Otologic Pharmaceutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 30, 2020 | ||||
| Grant | Oct 1, 2017 | ||||
| Grant | Nov 19, 2014 | ||||
| Series A | Apr 3, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Otologic Pharmaceutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| i2E | Series A |
| Oklahoma Life Science Fund | Series A |
| United States Department of Defense | Grant |
| Presbyterian Health Foundation | Series A |
| Oklahoma Center for the Advancement of Science and Technology | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2020
$300K grant from Oklahoma Center for the Advancement of Science and Technology
For institutional investors. Book with your work email.
Otologic Pharmaceutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Otologic Pharmaceutics's valuation, stock price, and market status.
Is Otologic Pharmaceutics a public or private company?
Otologic Pharmaceutics is a private company.
What is the current stock price of Otologic Pharmaceutics?
Otologic Pharmaceutics is a private company, so its shares have no public market price. Caplight tracks Otologic Pharmaceutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Otologic Pharmaceutics worth (valuation)?
Valuation information for Otologic Pharmaceutics is not publicly available.
Can I buy Otologic Pharmaceutics stock?
Otologic Pharmaceutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Otologic Pharmaceutics's last funding round?
Otologic Pharmaceutics's most recent funding round was Grant on July 30, 2020.
Who are the main investors in Otologic Pharmaceutics?
Key investors in Otologic Pharmaceutics include i2E.
Will Otologic Pharmaceutics IPO soon?
No public IPO plans have been announced for Otologic Pharmaceutics.
How can I track Otologic Pharmaceutics secondary market activity?
Caplight tracks bids, offers, and trades in Otologic Pharmaceutics's shares on secondary markets.